# US Nephrectomy Market > US Nephrectomy Market Research Report: By Procedure (Open Nephrectomy, Laparoscopic nephrectomy, Robot-assisted Laparoscopic Surgery), By Indication (Kidney Cancer, Kidney Disease) and By End User (Hospitals, Clinics, Surgical Centers) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.65% - **2024:** $ 800 Million - **2025:** $ 861.2 Million - **2035:** $ 1,800 Million - **Key Players:** Medtronic (US), Johnson & Johnson (US), Baxter International (US), Boston Scientific (US), Stryker (US), Smith & Nephew (GB), Terumo Corporation (JP), Fresenius Medical Care (DE), Cook Medical (US) **Report ID:** MRFR/MED/11746-HCR · **Pages:** 100 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-nephrectomy-market-13271 --- ## Market Summary ## **US Nephrectomy Market Overview** As per MRFR analysis, the US Nephrectomy Market Size was estimated at 618.38 (USD Million) in 2023. The US Nephrectomy Market Industry is expected to grow from 644.35(USD Million) in 2024 to 1,123.19 (USD Million) by 2035. The US Nephrectomy Market CAGR (growth rate) is expected to be around 5.182% during the forecast period (2025 - 2035). ### **Key Trends of US Nephrectomy Market Highlighted** The US Nephrectomy Market is witnessing significant trends driven by the rising incidence of kidney diseases and the increasing need for organ transplantation. Advances in surgical techniques, such as minimally invasive nephrectomy, are becoming popular among surgeons and patients due to shorter recovery times and reduced hospital stays. This shift towards robotic-assisted surgeries enhances precision and minimizes complications, making these innovations crucial in patient care. Additionally, the growing awareness of chronic kidney disease and the necessity for timely interventions are prompting healthcare providers to invest more in nephrectomy procedures. Opportunities to be explored in the US market include the development of new surgical instruments and technologies that enhance surgical outcomes and patient safety. As the population ages, there is a growing demand for targeted treatments that address various kidney disorders, which can encourage medical device manufacturers to expand their product lines. Furthermore, partnerships between hospitals and technology firms could lead to better availability of advanced surgical solutions, optimizing [nephrectomy](../../../reports/nephrectomy-market-5356) procedures across the country. Recent trends indicate a shift towards outpatient nephrectomy surgeries, emphasizing the adoption of less invasive techniques that cater to the needs of patients. Healthcare facilities are moving towards value-based care, which focuses on patient outcomes and satisfaction, further promoting the use of nephrectomy. In addition, legislative efforts aimed at improving access to care and funding for kidney disease research are creating a supportive environment for growth in this market segment. The strong emphasis on improving healthcare delivery in the US is enhancing the overall landscape for nephrectomy practices. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **US Nephrectomy Market Drivers** #### **Increasing Incidence of Kidney Diseases** The rising prevalence of kidney diseases, including chronic kidney disease and kidney cancer, is a significant driver of growth in the US Nephrectomy Market Industry. According to the Centers for Disease Control and Prevention (CDC), approximately 37 million Americans are estimated to have chronic kidney disease, with about 1 in 7 adults affected. Furthermore, the American Cancer Society reports that kidney cancer cases have been on the rise, with an expected 81,800 new cases in 2022 alone.This growing patient population necessitates surgical interventions like nephrectomy, thus boosting market demand. Established organizations such as the National Kidney Foundation are actively promoting awareness and providing resources, underlining the importance of addressing kidney health and cancer, which further emphasizes market growth potential as interventional solutions become critical. #### **Advancements in Surgical Techniques** Innovations in surgical techniques, particularly minimally invasive procedures, are driving the growth of the US Nephrectomy Market Industry. Techniques such as laparoscopic nephrectomy and robotic-assisted surgeries have gained popularity due to their associated benefits of reduced post-operative pain, quicker recovery times, and shorter hospital stays. The increased adoption of robotic systems, such as those developed by Intuitive Surgical, shows a significant impact on surgical outcomes, as studies indicate that patients undergoing robotic surgeries experience a 40% decrease in pain scores.Furthermore, the American Urological Association promotes the use of advanced technologies, reflecting a shift towards more effective and efficient treatment modalities in nephrectomy practices. #### **Growing Geriatric Population** The aging population in the United States is an important market driver for the US Nephrectomy Market Industry. According to the U.S. Census Bureau, the number of individuals aged 65 and older is projected to reach over 76 million by 2035, which correlates with an increased incidence of kidney-related issues. Older adults are at a higher risk for developing chronic kidney disease and other related conditions, leading to a greater need for surgical interventions like nephrectomy.Additionally, the American Geriatrics Society emphasizes the need for tailored treatment approaches for this demographic, further supporting the growing demand for nephrectomies as part of comprehensive healthcare strategies. #### **Rising Awareness and Screening Initiatives** Increased awareness about kidney health and proactive screening initiatives contribute to the growth of the US Nephrectomy Market Industry. The National Kidney Foundation and similar organizations are actively promoting educational campaigns aimed at enhancing public understanding of kidney diseases and their risks. As reported by the National Institute of Diabetes and Digestive and Kidney Diseases, awareness initiatives led to a significant increase in early diagnosis rates, with a 20% rise in screenings for kidney disease within five years.Such advancements in early detection result in a higher likelihood of surgical intervention, thereby driving market growth as practitioners are more likely to recommend nephrectomy for diagnosed patients. ### **US Nephrectomy Market Segment Insights** #### **Nephrectomy Market Procedure Insights** The US Nephrectomy Market, particularly the Procedure segment, plays a critical role in the treatment strategies for kidney-related disorders. Procedures like Open Nephrectomy, Laparoscopic Nephrectomy, and Robot-assisted Laparoscopic Surgery are essential methods employed in the surgical management of renal diseases. Open Nephrectomy, a traditional approach, enables surgeons to directly access the kidneys and may be utilized in complicated cases where extensive visualization is necessary. This method, while effective, is known for a longer recovery period due to increased surgical trauma. Conversely, Laparoscopic Nephrectomy, which involves smaller incisions, is gaining traction in the market due to its advantages such as decreased postoperative pain, shortened recovery times, and minimal scarring. This technique allows for a better cosmetic outcome while maintaining high efficacy in kidney removal. The newer innovation of Robot-assisted Laparoscopic Surgery is rapidly emerging as a preferred solution, as it enhances precision through advanced robotic technology, improving surgical outcomes and reducing the potential for complications.This has made Robot-assisted Laparoscopic Surgery particularly appealing to institutions striving for improved patient care. The US Nephrectomy Market is also being driven by factors such as the aging population, an increase in the prevalence of kidney disease, and greater public awareness of surgical options. However, it faces challenges like high costs associated with advanced technologies and varying degrees of surgeon experience with newer techniques. Nevertheless, opportunities for growth remain as healthcare providers increasingly adopt minimally invasive techniques, positioning the Procedure segment prominently within the broader US Nephrectomy Market landscape.This evolution in surgical methodologies aligns with current trends toward enhanced patient care and improved surgical efficiencies, contributing significantly to the advancements in the US Nephrectomy Market statistics. The integration of these procedures into routine practice reflects a broad shift towards prioritizing minimally invasive approaches in surgical treatments, highlighting the important role each procedure plays in achieving optimal patient outcomes in the US. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review #### **Nephrectomy Market Indication Insights** The US Nephrectomy Market is primarily driven by various indications, with significant focus on conditions such as Kidney Cancer and Kidney Disease. Kidney Cancer has become a leading indication for nephrectomy procedures, reflecting a rising incidence of renal cell carcinoma across the population. This trend aligns with increased awareness and advancements in diagnostic imaging, leading to earlier detection and treatment options. Concurrently, Kidney Disease, including chronic kidney disease, is a considerable contributor to the demand for nephrectomy, as patients progress to stages that necessitate surgical intervention. The combination of an aging population, lifestyle factors, and a growing prevalence of diabetes and hypertension creates a substantial burden of kidney-related health issues in the US. These factors not only necessitate surgical procedures but also drive innovations in treatment technologies, enhancing patient outcomes. The diverse indications within the nephrectomy market highlight the importance of surgical interventions in managing these life-threatening and chronic conditions. Overall, the US Nephrectomy Market segmentation reflects a landscape shaped by both rising patient needs and continuous advancements in medical practices and technologies. #### **Nephrectomy Market End User Insights** The End User segment of the US Nephrectomy Market encompasses various healthcare settings, particularly hospitals, clinics, and surgical centers, each playing a crucial role in delivering nephrectomy procedures. Hospitals are the primary environments for surgical interventions, equipped with advanced technology, critical care facilities, and specialized staff to handle complex cases. Clinics increasingly offer minimally invasive nephrectomy options, catering to the growing demand for outpatient services, which reflects a significant trend towards improved patient convenience and reduced hospital stays.Surgical centers provide a valuable alternative, focusing on same-day discharge solutions that enhance efficiency and patient turnover. The US Nephrectomy Market, characterized by rising incidences of kidney diseases and increased awareness of surgical options, is expected to see growth driven by technological advancements and the need for specialized care in these settings. As a result, hospitals and surgical centers are often viewed as key players due to their capacity to address the complexities of nephrectomy procedures effectively. The segmentation of the market highlights the unique attributes of each category, emphasizing the diversity of approaches in delivering nephrectomy services across the nation.This dynamic landscape reflects the adaptability of the US healthcare system in meeting patient needs while advancing surgical care options. ### **US Nephrectomy Market Key Players and Competitive Insights** The US Nephrectomy Market is a segment characterized by the surgical removal of one or both kidneys, which can be necessitated by various conditions, including renal cancer and kidney diseases. The competitive landscape of this market is shaped by advancements in surgical methods, technologies, and an increasing demand for minimally invasive procedures. As healthcare providers focus on improving patient outcomes, there is a heightened emphasis on innovation and efficiency in nephrectomy procedures. The market is populated by numerous companies that contribute to the development of surgical instruments, imaging technologies, and associated products designed specifically for nephrectomy, thereby intensifying competition among key players striving to capture market share in this specialized field. #### **Hologic** Hologic has established a significant presence in the US Nephrectomy Market through its innovative product offerings and commitment to advancing medical technologies. The company is well-regarded for its focus on women's health and has made strides in expanding its portfolio to address nephrectomy needs effectively. Hologic leverages state-of-the-art imaging technologies and minimally invasive surgical solutions that cater specifically to renal surgeons and healthcare institutions. Its strong emphasis on research and development enables Hologic to maintain a competitive edge, ensuring that its products not only meet industry standards but also enhance patient care quality. This dedication to innovation, coupled with strategic collaborations and partnerships within the healthcare sector, positions Hologic as a formidable player in the US Nephrectomy Market. #### **Integra LifeSciences** Integra LifeSciences is a prominent entity within the US Nephrectomy Market, recognized for its comprehensive range of surgical products and services catering to kidney surgery. The company offers various solutions, including advanced surgical instruments and biomaterials that support nephrectomy procedures. With its steadfast commitment to quality and innovation, Integra LifeSciences capitalizes on its extensive expertise in tissue regeneration and surgical technologies. The company's robust market presence is further bolstered by targeted mergers and acquisitions, which enhance its portfolio and operational capabilities in the nephrectomy domain. Integra's focus on providing high-quality products that meet the needs of surgeons and healthcare facilities underpins its strengths, ensuring it remains a competitive force in the US Nephrectomy Market. ### **Key Companies in the US Nephrectomy Market Include** - Hologic - Integra LifeSciences - Boston Scientific - Medtronic - Abbott Laboratories - Baxter International - Acelity - Thermo Fisher Scientific - Stryker - ConMed - Siemens Healthineers - Cook Medical - Johnson and Johnson - Ethicon - Intuitive Surgical ### **US Nephrectomy Market Industry Developments** In the US Nephrectomy Market, recent developments highlight the growing interest in minimally invasive surgical techniques. Notable advancements include the increased adoption of robotic-assisted surgical systems, such as those offered by Intuitive Surgical, which enhance precision and reduce patient recovery times. Current market dynamics show strong growth, influenced by increasing incidences of kidney diseases and associated treatments. Furthermore, Baxter International has expanded its portfolio of renal care solutions to address this growing demand. In terms of mergers and acquisitions, Hologic announced the acquisition of a smaller firm in September 2023, enhancing its capabilities in women's health and kidney disease. Similarly, in June 2023, Siemens Healthineers finalized a strategic acquisition aimed at bolstering its medical imaging division, which plays a crucial role in nephrology. Over the last couple of years, the Nephrectomy Market in the US has witnessed significant growth, particularly since the onset of the COVID-19 pandemic, which emphasized the need for advanced surgical solutions. Reports indicate that the market is expected to continue expanding rapidly, driven by technological innovations and increasing healthcare expenditures, fostering a competitive landscape among key players like Medtronic, Boston Scientific, and Johnson and Johnson. ### **US Nephrectomy Market Segmentation Insights** #### **Nephrectomy Market Procedure Outlook** #### **Nephrectomy Market Indication Outlook** #### **Nephrectomy Market End User Outlook** - Hospitals - Clinics - Surgical Centers ## Market Drivers ### Rising Incidence of Kidney Diseases The nephrectomy market is significantly influenced by the rising incidence of kidney diseases, including chronic kidney disease (CKD) and renal cell carcinoma. According to the Centers for Disease Control and Prevention (CDC), CKD affects nearly 15% of the adult population in the US, leading to a higher demand for nephrectomy procedures. As the prevalence of these conditions continues to rise, healthcare providers are likely to recommend surgical interventions more frequently. This trend is expected to drive the nephrectomy market, with estimates suggesting that the number of nephrectomy surgeries could increase by 10% annually. Consequently, the market is poised for substantial growth as healthcare systems adapt to the increasing burden of kidney-related diseases. ### Aging Population and Healthcare Access The aging population in the US is a critical factor influencing the nephrectomy market. As individuals age, the risk of developing kidney-related diseases escalates, necessitating surgical interventions such as nephrectomy. The US Census Bureau projects that by 2030, approximately 20% of the population will be 65 years or older, leading to a higher demand for healthcare services. Additionally, improved access to healthcare facilities and insurance coverage is likely to facilitate timely surgical procedures. This demographic shift is expected to drive the nephrectomy market, with estimates indicating a potential growth of 8% in surgical procedures annually as the healthcare system adapts to the needs of an aging population. ### Increased Awareness and Screening Programs Increased awareness of kidney health and the implementation of screening programs are pivotal drivers of the nephrectomy market. Public health initiatives aimed at educating the population about kidney diseases have led to earlier detection and diagnosis. As more individuals undergo routine screenings, the identification of conditions requiring nephrectomy is likely to rise. This proactive approach to kidney health is expected to contribute to a 7% increase in nephrectomy procedures over the next few years. Furthermore, healthcare providers are increasingly advocating for regular check-ups, which may further bolster the nephrectomy market as more patients are referred for surgical evaluation. ### Regulatory Support and Reimbursement Policies Regulatory support and favorable reimbursement policies are essential drivers of the nephrectomy market. The Centers for Medicare & Medicaid Services (CMS) has implemented policies that enhance reimbursement rates for nephrectomy procedures, making them more financially viable for healthcare providers. This support encourages hospitals to invest in nephrectomy services and expand their surgical offerings. Furthermore, the introduction of bundled payment models may incentivize efficient care delivery, potentially increasing the number of nephrectomy surgeries performed. As reimbursement frameworks evolve, the nephrectomy market is likely to benefit, with projections suggesting a 6% growth in the number of procedures performed annually, reflecting the positive impact of regulatory changes. ### Technological Advancements in Surgical Equipment The nephrectomy market is experiencing a surge in demand due to rapid technological advancements in surgical equipment. Innovations such as high-definition imaging systems and advanced laparoscopic tools enhance surgical precision and patient outcomes. The integration of artificial intelligence in surgical planning and execution is also gaining traction, potentially improving efficiency and reducing complications. As hospitals and surgical centers invest in state-of-the-art equipment, the nephrectomy market is likely to expand. In 2025, the market is projected to reach approximately $2 billion, reflecting a compound annual growth rate (CAGR) of around 5%. This growth is indicative of the increasing reliance on advanced technologies in surgical procedures. ## Future Outlook The [Nephrectomy Market](https://www.marketresearchfuture.com/reports/nephrectomy-market-5356) is projected to grow at a 7.65% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of kidney diseases, and rising healthcare expenditures. **New opportunities:** - Development of minimally invasive surgical instruments for nephrectomy procedures. - Expansion of telehealth services for pre- and post-operative care. - Investment in AI-driven diagnostic tools to enhance patient selection for nephrectomy. By 2035, the nephrectomy market is expected to achieve substantial growth, reflecting evolving healthcare dynamics. ## Segment Insights ### By Procedure: Laparoscopic Nephrectomy (Largest) vs. Robot-assisted Laparoscopic Surgery (Fastest-Growing) In the US nephrectomy market, Laparoscopic Nephrectomy commands the largest share, driven by its minimally invasive nature, which is preferred by both surgeons and patients. Open Nephrectomy, while still significant, is gradually declining as new technologies and methods gain traction. Robot-assisted Laparoscopic Surgery is emerging rapidly, capturing increasing attention due to its precision and improved outcomes. Growth trends indicate a noticeable shift toward less invasive techniques, with Laparoscopic Nephrectomy leading the way. Factors such as technological advancements, increasing demand for quicker recovery times, and reduced hospital stays are propelling this segment forward. Furthermore, the rapid adoption of robotic systems in surgical procedures highlights the potential for Robot-assisted Laparoscopic Surgery to grow faster than traditional methods, catering to a modern patient demographic that favors minimal invasiveness. Laparoscopic Nephrectomy (Dominant) vs. Robot-assisted Laparoscopic Surgery (Emerging) Laparoscopic Nephrectomy is widely recognized as the dominant procedure in the current landscape of the US nephrectomy market. Its advantages include minimal scarring, reduced postoperative pain, and shorter recovery times compared to Open Nephrectomy. Patients increasingly favor this approach, influencing surgeons toward laparoscopic techniques. On the other hand, Robot-assisted Laparoscopic Surgery represents an emerging trend that combines the principles of laparoscopic surgery with robotics, allowing for greater precision and dexterity. This method is gaining traction due to technological innovations, leading to better patient outcomes and lower complication rates. As hospitals invest in robotic surgical systems, Robot-assisted Laparoscopic Surgery is expected to grow at an accelerated pace, complementing the established practices of traditional laparoscopic surgery. ### By Indication: Kidney Cancer (Largest) vs. Other Kidney Diseases (Fastest-Growing) The market share distribution within the indication segment of the US nephrectomy market is primarily driven by the prevalence of kidney cancer, which constitutes the largest portion of the segment. Kidney cancer accounts for a significant share as ongoing advancements in detection and treatment methods have increased its visibility, leading to timely procedures. In contrast, other kidney diseases, while holding a smaller share currently, are expected to see an uptick as awareness and diagnosis improve, along with the implementation of new treatment protocols. Growth trends indicate that kidney cancer remains the dominant force in the market, fueled by increasing incidence rates and advancements in surgical techniques. Concurrently, the other kidney diseases segment is recognized as the fastest-growing due to evolving healthcare policies and technological innovations that enhance patient outcomes. This dual growth is attributed to the rising demand for effective nephrectomy solutions and a growing focus on improving the overall management of kidney health in the US. Kidney Cancer (Dominant) vs. Other Kidney Diseases (Emerging) Kidney cancer has established itself as the dominant indication in the US nephrectomy market, characterized by high surgical intervention rates and strong clinical focus. This segment benefits from ongoing research, targeted therapies, and a comprehensive care approach, ensuring that patients receive the most effective treatments. On the other hand, other kidney diseases represent an emerging segment, gaining traction as healthcare providers recognize the necessity of addressing a broader spectrum of kidney-related ailments. Factors such as an aging population, lifestyle changes, and increased screening practices for renal issues are contributing to the growth of this segment, potentially leading to greater clinical advancements and tailored therapeutic strategies in the near future. ### By End User: Hospitals & Clinics (Largest) vs. Surgical Centers (Fastest-Growing) In the US nephrectomy market, the distribution of market share among end users reveals a significant dominance of hospitals and clinics, which account for the largest segment due to their comprehensive facilities and access to advanced surgical technologies. Surgical centers are gaining traction, steadily increasing their share as they become preferred options for selective procedures, resulting in a competitive environment that reshapes the market dynamics. The growth trends in the end user segment reflect a shift towards outpatient services and minimally invasive procedures. Surgical centers are rapidly evolving, driven by technological advancements and a focus on cost-effectiveness. As patient preferences shift towards less invasive surgeries with lower recovery times, surgical centers are positioned to capture a larger share, supported by favorable reimbursement policies and increasing surgical volumes in this domain. Hospitals & Clinics (Dominant) vs. Surgical Centers (Emerging) Hospitals and clinics represent the dominant force in the US nephrectomy market, characterized by their extensive resources and capability to perform complex surgeries reliably. They benefit from established relationships with insurance providers, ensuring robust patient access and reimbursement. Conversely, surgical centers are emerging as significant competitors, offering specialized services in a streamlined environment that prioritizes patient comfort and efficient care. These centers leverage new technology and optimized workflows to cater to a growing number of patients seeking less invasive treatment options. This trend indicates a notable shift in surgical care delivery, with patients increasingly favoring settings that minimize hospital stays and promote faster recovery. ## Competitive Benchmarking The nephrectomy market exhibits a dynamic competitive landscape characterized by rapid technological advancements and a growing emphasis on minimally invasive surgical techniques. Key players such as Medtronic (US), Johnson & Johnson (US), and Baxter International (US) are strategically positioned to leverage innovation and expand their market share. Medtronic (US) focuses on enhancing its robotic-assisted surgical systems, which aligns with the increasing demand for precision in nephrectomy procedures. Meanwhile, Johnson & Johnson (US) emphasizes partnerships with healthcare providers to improve patient outcomes through advanced surgical solutions. Baxter International (US) is concentrating on supply chain optimization to ensure the availability of critical surgical products, thereby enhancing its operational efficiency and market responsiveness.The nephrectomy market appears moderately fragmented, with several players vying for dominance. Companies are adopting various business tactics, such as localizing manufacturing to reduce costs and improve supply chain resilience. This strategy not only enhances operational efficiency but also allows companies to respond swiftly to regional market demands. The collective influence of these key players shapes a competitive structure that encourages innovation and collaboration, ultimately benefiting healthcare providers and patients alike. In October Medtronic (US) announced the launch of its latest robotic-assisted surgical platform, designed specifically for nephrectomy procedures. This innovative system integrates advanced imaging technology and AI-driven analytics, which could potentially enhance surgical precision and reduce recovery times for patients. The introduction of this platform signifies Medtronic's commitment to leading the market through technological advancements, positioning it favorably against competitors. In September Johnson & Johnson (US) entered into a strategic partnership with a leading healthcare provider to develop a comprehensive training program for surgeons specializing in nephrectomy. This initiative aims to improve surgical techniques and patient outcomes, reflecting Johnson & Johnson's focus on education and collaboration within the healthcare ecosystem. Such partnerships may enhance the company's reputation and foster loyalty among healthcare professionals. In August Baxter International (US) expanded its product portfolio by acquiring a smaller firm specializing in innovative nephrology devices. This acquisition is likely to bolster Baxter's capabilities in providing comprehensive solutions for nephrectomy procedures, thereby enhancing its competitive edge. The move underscores Baxter's strategy of growth through acquisition, allowing it to diversify its offerings and strengthen its market position. As of November the nephrectomy market is increasingly influenced by trends such as digitalization, sustainability, and the integration of AI technologies. Companies are recognizing the importance of strategic alliances to navigate these trends effectively. The competitive landscape is shifting from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This evolution suggests that future differentiation will hinge on the ability to deliver cutting-edge solutions that enhance surgical outcomes and operational efficiencies. ## Recent News & Developments In the US Nephrectomy Market, recent developments highlight the growing interest in minimally invasive surgical techniques. Notable advancements include the increased adoption of robotic-assisted surgical systems, such as those offered by Intuitive Surgical, which enhance precision and reduce patient recovery times. Current market dynamics show strong growth, influenced by increasing incidences of kidney diseases and associated treatments. Furthermore, Baxter International has expanded its portfolio of renal care solutions to address this growing demand. In terms of mergers and acquisitions, Hologic announced the acquisition of a smaller firm in September 2023, enhancing its capabilities in women's health and kidney disease. Similarly, in June 2023, Siemens Healthineers finalized a strategic acquisition aimed at bolstering its medical imaging division, which plays a crucial role in nephrology. Over the last couple of years, the Nephrectomy Market in the US has witnessed significant growth, particularly since the onset of the COVID-19 pandemic, which emphasized the need for advanced surgical solutions. Reports indicate that the market is expected to continue expanding rapidly, driven by technological innovations and increasing healthcare expenditures, fostering a competitive landscape among key players like Medtronic, Boston Scientific, and Johnson and Johnson. ## Report Scope | MARKET SIZE 2024 | 800.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 861.2(USD Million) | | MARKET SIZE 2035 | 1800.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.65% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Johnson & Johnson (US), Baxter International (US), Boston Scientific (US), Stryker (US), Smith & Nephew (GB), Terumo Corporation (JP), Fresenius Medical Care (DE), Cook Medical (US) | | Segments Covered | Procedure, Indication, End User | | Key Market Opportunities | Advancements in minimally invasive techniques enhance patient outcomes in the nephrectomy market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the nephrectomy market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the current valuation of the US nephrectomy market in 2025?** A: The US nephrectomy market is valued at $800.0 Million in 2024 and is projected to grow significantly. **Q: What is the expected CAGR for the US nephrectomy market from 2025 to 2035?** A: The expected CAGR for the US nephrectomy market during the forecast period 2025 - 2035 is 7.65%. **Q: Which companies are the key players in the US nephrectomy market?** A: Key players in the US nephrectomy market include Medtronic, Johnson & Johnson, Baxter International, and Boston Scientific. **Q: What are the major segments of the US nephrectomy market?** A: The major segments of the US nephrectomy market include procedures, indications, and end users. **Q: How does the valuation of laparoscopic nephrectomy compare to open nephrectomy?** A: Laparoscopic nephrectomy is valued between $300.0 Million and $800.0 Million, whereas open nephrectomy is valued between $200.0 Million and $450.0 Million. **Q: What is the projected market valuation for the US nephrectomy market by 2035?** A: The projected valuation for the US nephrectomy market by 2035 is $1800.0 Million. **Q: What are the indications driving the US nephrectomy market?** A: The primary indications driving the US nephrectomy market are kidney cancer and other kidney diseases, each valued between $400.0 Million and $900.0 Million. **Q: Which end users are contributing to the US nephrectomy market growth?** A: End users contributing to the US nephrectomy market growth include hospitals & clinics, surgical centers, and others. **Q: What is the valuation range for robot-assisted laparoscopic surgery in the US nephrectomy market?** A: Robot-assisted laparoscopic surgery is valued between $300.0 Million and $550.0 Million in the US nephrectomy market. **Q: How does the market for surgical centers compare to hospitals & clinics in the US nephrectomy market?** A: The market for surgical centers is valued between $240.0 Million and $540.0 Million, while hospitals & clinics are valued between $400.0 Million and $900.0 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-nephrectomy-market-13271*